Fig. 3From: B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patientsRelationship between B4GALT1 expression and benefit from adjuvant chemotherapy (ACT). Survival curves for pT3/4 or N+ patients with ACT and without ACT in combined cohorts (left) and in low B4GALT1 expression subgroup (middle) and in high B4GALT1 expression subgroup (right). P value was calculated by log-rank testBack to article page